Glaser, A. P., Fantini, D., Wang, Y., Yu, Y., Rimar, K. J., Podojil, J. R., . . . Meeks, J. J. (2017). APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response. Oncotarget.
Chicago Style aipamenaGlaser, Alexander P., Damiano Fantini, Yiduo Wang, Yanni Yu, Kalen J. Rimar, Joseph R. Podojil, Stephen D. Miller, and Joshua J. Meeks. "APOBEC-mediated Mutagenesis in Urothelial Carcinoma Is Associated With Improved Survival, Mutations in DNA Damage Response Genes, and Immune Response." Oncotarget 2017.
MLA aipamenaGlaser, Alexander P., et al. "APOBEC-mediated Mutagenesis in Urothelial Carcinoma Is Associated With Improved Survival, Mutations in DNA Damage Response Genes, and Immune Response." Oncotarget 2017.